Published in AIDS Weekly, June 7th, 2004
According to recent research from Italy, "A series of 3- and 5-methylthiophene-2-carboxaldehyde alpha-(N)-heterocyclichydrazones were synthesized and submitted to an in vitro investigation of their anticancer, anti-HIV and antimicrobial activities."
"Some of the newly synthesized compounds were found to possess antiproliferative properties, whereas no anti-HIV activity was seen: the most active of the series was the derivative 2i, which exhibited turnout growth inhibition activity against all cell lines displaying...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.